KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Imax (IMAX) Liabilities and Shareholders Equity (2016 - 2025)

Imax (IMAX) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $894.0 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 7.66% to $894.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.5 billion through Dec 2025, up 5.14% year-over-year, with the annual reading at $894.0 million for FY2025, 7.66% up from the prior year.
  • Liabilities and Shareholders Equity hit $894.0 million in Q4 2025 for Imax, up from $889.6 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $942.4 million in Q1 2021 to a low of $800.2 million in Q3 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $849.3 million across 5 years, with a median of $847.9 million in 2024.
  • Biggest five-year swings in Liabilities and Shareholders Equity: dropped 16.92% in 2021 and later grew 7.66% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $883.2 million in 2021, then dropped by 7.03% to $821.2 million in 2022, then dropped by 0.79% to $814.7 million in 2023, then grew by 1.93% to $830.4 million in 2024, then increased by 7.66% to $894.0 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for IMAX at $894.0 million in Q4 2025, $889.6 million in Q3 2025, and $868.6 million in Q2 2025.